**Core Concept**
Myasthenia gravis (MG) is an autoimmune disease characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by the production of antibodies against the acetylcholine receptor (AChR) at the neuromuscular junction (NMJ), leading to a decrease in acetylcholine receptor density and impaired neurotransmission.

**Why the Correct Answer is Right**
The correct answer is associated with the pathophysiology of myasthenia gravis. In MG, autoantibodies target the nicotinic acetylcholine receptor (nAChR) on the postsynaptic muscle membrane, leading to a reduction in the number of functional AChR. This results in impaired synaptic transmission, characterized by a decrease in the amplitude of the end-plate potential (EPP) and an increase in the threshold for muscle contraction. The resulting muscle weakness and fatigue are classic symptoms of MG.

**Why Each Wrong Option is Incorrect**
**Option A:** Thymoma is associated with myasthenia gravis, but it is not the correct answer. While thymomas are found in approximately 10-15% of MG patients, the disease is not exclusively linked to thymic abnormalities.

**Option B:** This option is not relevant to myasthenia gravis. While various autoimmune diseases are associated with specific HLA haplotypes, myasthenia gravis is not primarily linked to HLA typing.

**Option C:** This option is incorrect. Myasthenia gravis is not typically associated with an increase in muscle tone. Instead, patients often present with muscle weakness and fatigue.

**Clinical Pearl / High-Yield Fact**
The Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder that is often mistaken for myasthenia gravis. However, LEMS is characterized by an increase in acetylcholine receptor density at the NMJ and is typically associated with small-cell lung cancer.

**Correct Answer:** Thymoma.